Horton, a fourth-round pick by the Texans in 2023, played in 10 games as a rookie before stepping away from the team in late ...

Patients with a rare blood cancer that has relapsed or become resistant to treatment have shown a high response rate to a ...

Nurse Dalton Cummins can truly relate to his oncology patients at Riley Hospital for Children. After all, he was once a ...

India continues to see a steady rise in the incidence of lymphoma, the most common type of blood cancer. But among all the ...

In light of National Lymphoma Awareness Month, one Arkansan shares his cancer journey after a stage 4 Hodgkin's lymphoma ...

A recent study derived from the adverse event reporting system of the Food and Drug Administration (FDA) showed that T-cell non-Hodgkin lymphomas were identified in 17 of 536 reports (3.2% ...

DLBCL is a type of non-Hodgkin’s lymphoma (NHL). It is the most common NHL, accounting for around 85% of these lymphomas. Medical professionals classify NHLs according to the speed at which they ...

July 22, 2024 — The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for ...

September is Leukemia & Lymphoma Awareness Month. Oncologists diagnosed Skarzinski with stage 4 non-Hodgkin's B cell Lymphoma ...

Houston Texans defensive end Dylan Horton was activated from the reserve/non-football injured list Saturday, less than a year after he was diagnosed with late-stage Hodgkin lymphoma ...

Primary non-Hodgkin's lymphoma of the breast (PBNHL) is uncommon. There have been only a few reports of breast lymphoma in the radiology literature. In this case report, we describe mammographic ...

Panelists discuss how bispecific antibodies are transforming the treatment landscape for non-Hodgkin lymphoma by enhancing T ...